Brucker, Sara, 1974-
Brucker, Sara Y. (1974- ).
Brucker, Sara Y.
Sara Brucker
VIAF ID: 64881462 ( Personal )
Permalink: http://viaf.org/viaf/64881462
Preferred Forms
- 100 1 _ ‡a Brucker, Sara Y.
-
-
- 100 1 _ ‡a Brucker, Sara ‡d 1974-
- 100 1 _ ‡a Brucker, Sara, ‡d 1974-
- 100 0 _ ‡a Sara Brucker
4xx's: Alternate Name Forms (9)
5xx's: Related Names (2)
Works
Title | Sources |
---|---|
Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial | |
Atlas of breast surgery | |
clinical relevance of the NATALEE study: application of the NATALEE criteria to a real-world cohort from two large German breast cancer centers | |
Diagnostyka wad żeńskich narządów płciowych / Grigoris F. Grimbizis [i inni] // Medycyna Praktyczna. Ginkologia i Położnictwo. - 6 (106) 2016, strony 33-54, 90. | |
Endometrial hyperplasia as a risk factor of endometrial cancer | |
Frauengesundheit - Frauenmedizin fachübergreifend und kompakt | |
Gynäkologische Onkologie Prolog für die DKG: Olaf Ortmann, Geleitwort für die DGS: Rüdiger Schulz-Wendtland, Prolog für die AGO: Tanja Fehm | |
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study | |
Onkologische CME-Kurse adjuvante endokrine Therapie des frühen Hormonrezeptor-positiven Mammakarzinoms der postmenopausalen Patientin | |
Präattentive visuelle Informationsverarbeitung bei Patienten mit Morbus Parkinson | |
Prenatal dexamethasone treatment for classic 21-hydroxylase deficiency in Europe | |
Recurrence Score® result impacts treatment decisions in hormone receptor-positive, HER2-negative patients with early breast cancer in a real-world setting - results of the IRMA trial | |
Statement of the uterus commission of the gynecological oncology working group (AGO) on the use of primary chemoimmunotherapy to treat patients with locally advanced or recurrent endometrial cancer | |
Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies | |
Tumor-free resection margin distance in the surgical treatment of node-negative squamous cell cancer of the vulva has no impact on survival: analysis of a large patient cohort in a tertiary care center | |
Vaginalaplasie aktuelle Diagnose- und Therapiekonzepte |